Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qingyan Lihou Decoction for Chronic Pharyngolaryngitis
NCT05665777Phase 2Recruiting
- Sponsor
- The Chinese University of Hong Kong
- Start
- Mar 2023
- Primary completion
- Jan 2027
- Modality
- HM (Herbal Medicine), NPI (Non-Pharmacological Intervention), Dietary Supplement
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Pharyngolaryngitis comparing Active treatment (Qingyan Lihou Decoction) with Placebo (2 arms). Primary endpoints: Resolution rate of the clinical symptoms of CP at 8 weeks and Improvement of laryngeal signs at 8 weeks. Started Mar 2023; status: recruiting.
02
Drugs
Qingyan Lihou Decoction
03
Conditions
Pharyngolaryngitis
Beyond the preview
Go deeper on NCT05665777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05665777.